Effie’s mission is to lead, inspire, and champion the practice and practitioners of marketing effectiveness globally. For almost three decades, the Effie Awards Europe have been the pinnacle of recognition for agencies and brands, inspiring and celebrating work that works, setting the bar for marketing effectiveness in the region.
In 2025, Effie Europe, in collaboration with EACA’s Health Communications Council, introduced a new category to put a spotlight on the healthcare industry’s marketing efforts having a positive impact on health outcomes.
The Health Effectiveness category celebrates marketing efforts proven effective in making a positive impact on health outcomes at an individual and societal level.
Winners of this award will be recognized for innovative marketing strategies, technologies or creative approaches that bring about change to improve patients’ lives.
Audiences can include, but are not limited to, patients, professionals, caregivers, advocacy groups.
Examples include improving patient understanding, engagement and treatment adherence or perhaps a change in healthcare professional behaviour or clinical practice.
Demonstration of significant collaboration with key healthcare stakeholders is important, as is the potential for long-term impact and scalability across regions or populations.
Entries must demonstrate clear results associated with improvements in health outcomes and be underpinned by data that provides a robust-evidence base. Enter in one of two sub-categories:
Note: There is a special entry form required for the Health Effectiveness category.
Note 2: Effie Europe offers a €200 off entry fees for new agencies or those that haven’t submitted an entry in the last 3 years.
Not sure where to begin? Take inspiration from UCB and Ogilvy Health UK's Rare Disease Connect in Neurology (RDCN), a 2025 Silver Effie winner in Health Effectiveness that shows how bold collaboration delivers lasting impact.
Rare neurological diseases like myasthenia gravis leave patients battling delayed diagnoses and suboptimal care in a fragmented expert landscape. RDCN transformed this by launching a multi-market, expert-led platform - blending annual Amsterdam summits with ongoing digital modules - for peer-to-peer learning and outcomes-driven education. Guided by a global steering committee, it tackled real clinical gaps via case-based sessions, sparking 48% practice changes, 9/10 HCP impact scores, and 100% return intent. This enduring ecosystem not only elevated MG standards but redefined pharma's role in fostering global communities for lasting health impact.
